m6A mRNA methylation in brown fat regulates systemic insulin sensitivity via an inter-organ prostaglandin signaling axis independent of UCP1

Ling Xiao,Dario F De Jesus,Cheng-Wei Ju,Jiang Bo Wei,Jiang Hu,Ava DiStefano-Forti,Tadataka Tsuji,Cheryl Cero,Ville Männistö,Suvi M Manninen,Siying Wei,Oluwaseun Ijaduola,Matthias Blüher,Aaron M Cypess,Jussi Pihlajamäki,Yu-Hua Tseng,Chuan He,Rohit N Kulkarni
DOI: https://doi.org/10.1016/j.cmet.2024.08.006
2024-09-04
Abstract:Brown adipose tissue (BAT) regulates systemic metabolism by releasing signaling lipids. N6-methyladenosine (m6A) is the most prevalent and abundant post-transcriptional mRNA modification and has been reported to regulate BAT adipogenesis and energy expenditure. Here, we demonstrate that the absence of m6A methyltransferase-like 14 (METTL14) modifies the BAT secretome to improve systemic insulin sensitivity independent of UCP1. Using lipidomics, we identify prostaglandin E2 (PGE2) and prostaglandin F2a (PGF2a) as BAT-secreted insulin sensitizers. PGE2 and PGF2a inversely correlate with insulin sensitivity in humans and protect mice from high-fat-diet-induced insulin resistance by suppressing specific AKT phosphatases. Mechanistically, METTL14-mediated m6A promotes the decay of PTGES2 and CBR1, the genes encoding PGE2 and PGF2a biosynthesis enzymes, in brown adipocytes via YTHDF2/3. Consistently, BAT-specific knockdown of Ptges2 or Cbr1 reverses the insulin-sensitizing effects in M14KO mice. Overall, these findings reveal a novel biological mechanism through which m6A-dependent regulation of the BAT secretome regulates systemic insulin sensitivity.
What problem does this paper attempt to address?